Progress in Pediatric Cardiology
Volume 21, Issue 2 , Pages 167-171 , March 2006

Bioengineered muscle constructs and tissue-based therapy for cardiac disease

References 

  1. Langer R, Vacanti JP. Tissue engineering. Science. 1993;260:920–926
  2. Langer RS, Vacanti JP. Tissue engineering: the challenges ahead. Sci Am. 1999;280:86–89
  3. Bach AD, Beier JP, Stein J, Horch RE. Skeletal muscle tissue engineering. J Cell Mol Med. 2004;8:413–422
  4. Ham RG, St.Clair JA, Webster C, Blau HM. Improved media for normal human skeletal muscle satellite cells: serum-free clonal growth and enhanced growth with low serum. In Vitro. 1988;24:833–844
  5. Allo SN, Carl LL, Morgan HE. Acceleration of growth of cultured cardiomyocytes and translocation of protein kinase C. Am J Physiol Cell Physiol. 1992;263:C319–C325
  6. Schlüter KD, Piper HM. Regulation of growth in the adult cardiomyocytes. FASEB J. 1999;13:17–22
  7. Hassink RJ, Dowell JD, Brutel R, Doevendans PA, Field LJ. Stem cell therapy for ischemic heart disease. Trends Mol Med. 2003;9:436–441
  8. Hughes S. Cardiac stem cells. J Pathol. 2002;197:468–478
  9. Vandenburgh HH, Solerssi R, Shansky J, Adams J, Henderson SA. Mechanical stimulation of organogenic cardiomyocyte growth in vitro. Am J Physiol (Cell Physiol). 1996;270:C1284–C1292
  10. Decker ML, Janes DM, Barclay MM, Harger L, Decker RS. Regulation of adult cardiocyte growth: effects of active and passive mechanical loading. Am J Physiol Heart Circ Physiol. 1997;272:H2902–H2918
  11. Samuel J-L, Vandenburgh HH. Mechanically induced orientation of adult rat cardiac myocytes in vitro. In Vitro. 1990;26:905–914
  12. Radisic M, Park H, Shing H, et al. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci U S A. 2004;101:18129–18134
  13. Vandenburgh HH. Dynamic mechanical orientation of skeletal myofibers in vitro. Dev Biol. 1982;93:438–443
  14. Lutolf MP, Hubbell JA. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol. 2005;23:47–55
  15. Papadaki M, Bursac N, Langer R, Merok J, Vunjak-Novakovic G, Freed LE. Tissue engineering of functional cardiac muscle: molecular, structural, and electrophysiological studies. Am J Physiol Heart Circ Physiol. 2001;280:H168–H178
  16. Bursac N, Papadaki M, Cohen RJ, et al. Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies. Am J Physiol Heart Circ Physiol. 1999;277:H433–H444
  17. Zimmermann WH, Fink C, Kralisch D, Remmers U, Weil J, Eschenhagen T. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol Bioeng. 2000;68:106–114
  18. Zimmermann WH, Schneiderbanger K, Schubert P, et al. Tissue engineering of a differentiated cardiac muscle construct. Circ Res. 2002;90:223–230
  19. Vandenburgh HH, Swasdison S, Karlisch P. Computer aided mechanogenesis of skeletal muscle organs from single cells in vitro. FASEB J. 1991;5:2860–2867
  20. Dennis RG, Kosnik PE. Excitability and isometric contractile properties of mammalian skeletal muscle constructs engineered in vitro. In Vitro Cell Dev Biol Anim. 2000;6(5):327–335
  21. Okano T, Matsuda T. Tissue engineered skeletal muscle: preparation of highly dense, highly oriented hybrid muscular tissues. Cell Transplant. 1998;7(1):71–82
  22. Fink C, Ergün S, Kralisch D, Remmers U, Weil J, Eschenhagen T. Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement. FASEB J. 2000;14:669–679
  23. Powell C, Smiley B, Mills J, Vandenburgh H. Mechanical stimulation improves tissue-engineered human skeletal muscle. Am J Physiol Cell Physiol. 2002;283:C1557–C1565
  24. Okano T, Matsuda T. Muscular tissue engineering: capillary-incorporated hybrid muscular tissues in vivo tissue culture. Cell Transplant. 1998;7(5):435–442
  25. Ennett AB, Mooney DJ. Tissue engineering strategies for in vivo neovascularisation. Expert Opin Biol Ther. 2002;2:805–818
  26. Levenberg S, Rouwkema J, Macdonald M, et al. Engineering vascularized skeletal muscle tissue. Nat Biotechnol. 2005;[advanced online publication]
  27. Bach AD, Beier JP, Stark GB. Expression of Trisk-á51, agrin and nicotinic-acetycholine receptor e-subunit during muscle development in a novel three-dimensional muscle-neuronal co-culture system. Cell Tissue Res. 2003;314:263–274
  28. Lu Y, Shansky J, Del Tatto M, Ferland P, Wang X, Vandenburgh H. Recombinant vascular endothelial growth factor secreted from tissue-engineered bioartificial muscles promotes localized angiogenesis. Circulation. 2001;104(5):594–599
  29. Thorrez L, Vandenburgh H, Collen D, Shansky J, VandenDriessche T, Chuah M. Enhanced factor IX delivery from bioengineered hybrid human skeletal muscle co-expressing VEGF. In: Am Soc Gene Therapy 8th Annual Mtg. (abstract). 2005;
  30. Urbanek K, Quaini F, Tasca G, et al. Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc Natl Acad Sci U S A. 2003;100(18):10440–10445
  31. Kajstura J, Leri A, Finato N, Di Loreto C, Beltrami CA, Anversa P. Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci U S A. 1998;95(15):8801–8805
  32. Murry CE, Wiseman RW, Schwartz SM, Hauschka SD. Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest. 1996;98:2512–2523
  33. Taylor DA, Atkins BZ, Hungspreugs P, et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med. 1998;4:929–933
  34. Hagege AA, Carrion C, Menasche P, et al. Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet. 2003;361:491–492
  35. Menasche P. Skeletal muscle satellite cell transplantation. Cardiovasc Res. 2003;58:351–357
  36. Menasche P. Skeletal myoblast for cell therapy. Coron Artery Dis. 2005;16(2):105–110
  37. Suzuki K, Brand NJ, Allen S, et al. Overexpression of connexin 43 in skeletal myoblasts: relevance to cell transplantation to the heart. J Thorac Cardiovasc Surg. 2001;122(4):759–766
  38. Suzuki K, Murtuza B, Smolenski RT, et al. Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts. Circulation. 2001;104(12 Suppl 1):I207–I212
  39. Murtuza B, Suzuki K, Bou-Gharios G, et al. Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardium. Proc Natl Acad Sci U S A. 2004;101(12):4216–4221
  40. Suzuki K, Murtuza B, Beauchamp JR, et al. Role of interleukin-1beta in acute inflammation and graft death after cell transplantation to the heart. Circulation. 2004;110(11 Suppl 1):II219–II224
  41. Vandenburgh H, Chromiak J, Shansky J, DelTatto M, LeMaire J. Space travel directly induces skeletal muscle atrophy. FASEB J. 1999;13:1031–1038
  42. Wakatsuki T, Fee JA, Elson EL. Phenotypic screening for pharmaceuticals using tissue constructs. Curr Pharm Biotech. 2004;5:181–189
  43. Gussoni E, Blau HM, Kunkel LM. The fate of individual myoblasts after transplantation into muscles of DMD patients. Nat Med. 1997;3:970–977
  44. Vandenburgh HH, Del Tatto M, Shansky J, et al. Tissue engineered skeletal muscle organoids for reversible gene therapy. Hum Gene Ther. 1996;7:2195–2200
  45. Vile RG, Russell SJ. Retroviruses as vectors. Br Med Bull. 1995;51:12–30
  46. Hacein-Bey-Abina S, von Kalle C, Schmidt M, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science. 2003;302(5644):415–419
  47. Lu QL, Bou-Gharios G, Partridge TA. Non-viral gene delivery in skeletal muscle: a protein factory. Gene Ther. 2003;10:131–142
  48. Vandenburgh H, Del Tatto M, Shansky J, et al. Attenuation of skeletal muscle wasting with recombinant human growth hormone secreted from a tissue-engineered bioartificial muscle. Hum Gene Ther. 1998;9:2555–2564
  49. Lu Y, Shansky J, Del Tatto M, et al. Therapeutic potential of implanted tissue-engineered bioartificial muscles delivering recombinant proteins in the sheep heart. Ann N Y Acad Sci. 2001;961:78–82
  50. Vandenburgh H, Thorrez L, Collen D, Shansky J, VandenDriessche T, Chuah MKL. Long-term transgene expression in vivo following implantation of adult human skeletal muscle stem cells transduced with lentiviral vectors. TESI Annual Mtg. vol. 181. 2004;Abstract
  51. Vandenburgh HH. In: Factor VIIIdeltaB Transduced Autologous Muscle Analog. Pre-IND Information Package for CBER Meeting. 2001;
  52. Fair JH, Cairns BA, LaPaglia MA, et al. Correction of factor IX deficiency in mice by embryonic stem cells differentiated in vitro. Proc Natl Acad Sci U S A. 2005;102:2958–2963

PII: S1058-9813(05)00082-2

doi: 10.1016/j.ppedcard.2005.11.003

Progress in Pediatric Cardiology
Volume 21, Issue 2 , Pages 167-171 , March 2006

Article Tools

* Image Usage & Resolution